248 related articles for article (PubMed ID: 30720541)
1. Use of Topical Rho Kinase Inhibitors in the Treatment of Fuchs Dystrophy After Descemet Stripping Only.
Macsai MS; Shiloach M
Cornea; 2019 May; 38(5):529-534. PubMed ID: 30720541
[TBL] [Abstract][Full Text] [Related]
2. Descemet Stripping Only Supplemented With Topical Ripasudil for Fuchs Endothelial Dystrophy 12-Month Outcomes of the Sydney Eye Hospital Study.
Moloney G; Garcerant Congote D; Hirnschall N; Arsiwalla T; Luiza Mylla Boso A; Toalster N; D'Souza M; Devasahayam RN
Cornea; 2021 Mar; 40(3):320-326. PubMed ID: 32740006
[TBL] [Abstract][Full Text] [Related]
3. Descemetorhexis Without Grafting for Fuchs Endothelial Dystrophy-Supplementation With Topical Ripasudil.
Moloney G; Petsoglou C; Ball M; Kerdraon Y; Höllhumer R; Spiteri N; Beheregaray S; Hampson J; DʼSouza M; Devasahayam RN
Cornea; 2017 Jun; 36(6):642-648. PubMed ID: 28476048
[TBL] [Abstract][Full Text] [Related]
4. Descemet's stripping without endothelial keratoplasty.
Garcerant D; Hirnschall N; Toalster N; Zhu M; Wen L; Moloney G
Curr Opin Ophthalmol; 2019 Jul; 30(4):275-285. PubMed ID: 31033737
[TBL] [Abstract][Full Text] [Related]
5. Potential Functional Restoration of Corneal Endothelial Cells in Fuchs Endothelial Corneal Dystrophy by ROCK Inhibitor (Ripasudil).
Schlötzer-Schrehardt U; Zenkel M; Strunz M; Gießl A; Schondorf H; da Silva H; Schmidt GA; Greiner MA; Okumura N; Koizumi N; Kinoshita S; Tourtas T; Kruse FE
Am J Ophthalmol; 2021 Apr; 224():185-199. PubMed ID: 33316261
[TBL] [Abstract][Full Text] [Related]
6. Descemet stripping only in Fuchs' endothelial dystrophy without use of topical Rho-kinase inhibitors: 5-year follow-up.
Iovieno A; Moramarco A; Fontana L
Can J Ophthalmol; 2022 Dec; 57(6):402-407. PubMed ID: 34283965
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Fuchs Endothelial Dystrophy by Descemet Stripping Without Endothelial Keratoplasty.
Borkar DS; Veldman P; Colby KA
Cornea; 2016 Oct; 35(10):1267-73. PubMed ID: 27310885
[TBL] [Abstract][Full Text] [Related]
8. Descemet Endothelial Thickness Comparison Trial 1 (DETECT 1): outcome masked, placebo-controlled trial comparing two types of corneal transplant surgeries and effect of rho kinase inhibitors on endothelial cell loss protocol.
Chamberlain W; Lin CC; Li JY; Gensheimer W; Clover J; Jeng BH; Varnado N; Abdelrahman S; Arnold BF; Lietman TM; Rose-Nussbaumer J
BMJ Open Ophthalmol; 2024 Jan; 9(1):. PubMed ID: 38286566
[TBL] [Abstract][Full Text] [Related]
9. Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) Transiently Alters the Morphology of Corneal Endothelial Cells.
Okumura N; Okazaki Y; Inoue R; Nakano S; Fullwood NJ; Kinoshita S; Koizumi N
Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7560-7. PubMed ID: 26618648
[TBL] [Abstract][Full Text] [Related]
10. Descemet stripping only and ripasudil for the treatment of traumatic Descemet's membrane ruptures.
Fernández López E; Montolío-Marzo S; Ortega Pérez C; Catalán Gómez M; Peris Martínez C; Piá Ludeña JV; Chan E
Eur J Ophthalmol; 2023 Jul; 33(4):NP13-NP18. PubMed ID: 35435049
[TBL] [Abstract][Full Text] [Related]
11. Failed Descemet Stripping Only (DSO) with Adjuvant Rho-Kinase Inhibitor Therapy in a Fuchs' Endothelial Dystrophy Patient: A Case Report.
Reinhold A; Eggenschwiler L; Meyer P; Goldblum D
Klin Monbl Augenheilkd; 2021 Apr; 238(4):376-377. PubMed ID: 33930913
[No Abstract] [Full Text] [Related]
12. Pilot Study of Corneal Clearance With the Use of a Rho-Kinase Inhibitor After Descemetorhexis Without Endothelial Keratoplasty for Fuchs Endothelial Corneal Dystrophy.
Davies E; Jurkunas U; Pineda R
Cornea; 2021 Jul; 40(7):899-902. PubMed ID: 33758139
[TBL] [Abstract][Full Text] [Related]
13. One year outcome of hemi-Descemet membrane endothelial keratoplasty.
Lam FC; Baydoun L; Satué M; Dirisamer M; Ham L; Melles GR
Graefes Arch Clin Exp Ophthalmol; 2015 Nov; 253(11):1955-8. PubMed ID: 26156680
[TBL] [Abstract][Full Text] [Related]
14. Rho kinase (ROCK) inhibitors in the management of corneal endothelial disease.
Syed ZA; Rapuano CJ
Curr Opin Ophthalmol; 2021 May; 32(3):268-274. PubMed ID: 33606407
[TBL] [Abstract][Full Text] [Related]
15. Descemet membrane endothelial keratoplasty as treatment for graft failure after descemet stripping automated endothelial keratoplasty.
Weller JM; Tourtas T; Kruse FE; Schlötzer-Schrehardt U; Fuchsluger T; Bachmann BO
Am J Ophthalmol; 2015 Jun; 159(6):1050-1057.e2. PubMed ID: 25790736
[TBL] [Abstract][Full Text] [Related]
16. Role of descemet's stripping without keratoplasty in management of endothelial disease.
Northey LC; Moloney G
Curr Opin Ophthalmol; 2023 Jul; 34(4):348-353. PubMed ID: 37254864
[TBL] [Abstract][Full Text] [Related]
17. Surgical Management of Fuchs Endothelial Corneal Dystrophy: A Treatment Algorithm and Individual Patient Meta-Analysis of Descemet Stripping Only.
Din N; Cohen E; Popovic M; Mimouni M; Trinh T; Gouvea L; Alshaker S; Ong Tone S; Chan CC; Slomovic AR
Cornea; 2022 Sep; 41(9):1188-1195. PubMed ID: 35942547
[TBL] [Abstract][Full Text] [Related]
18. Preliminary outcome of hemi-Descemet membrane endothelial keratoplasty for Fuchs endothelial dystrophy.
Gerber-Hollbach N; Parker J; Baydoun L; Liarakos VS; Ham L; Dapena I; Melles GR
Br J Ophthalmol; 2016 Nov; 100(11):1564-1568. PubMed ID: 26837507
[TBL] [Abstract][Full Text] [Related]
19. Medium-Term Failure of Descemet's Stripping Only and Fuchs' Dystrophy With Pancorneal Guttae.
Arsiwalla T; Trinh T; Goolam S; Benito-Pascual B; Devasahayam RN; Moloney G
Cornea; 2022 Aug; 41(8):1064-1067. PubMed ID: 35830584
[TBL] [Abstract][Full Text] [Related]
20. Does Same-Day Postoperative Increased Intraocular Pressure Affect Endothelial Cell Density After Descemet Membrane Endothelial Keratoplasty?
Fajgenbaum MAP; Hollick EJ
Cornea; 2018 Dec; 37(12):1484-1489. PubMed ID: 30222712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
